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Ambient mass concentrations of particulate 
matter (PM) air pollution < 2.5 µm (PM2.5) 
and < 10 µm (PM10) in aerodynamic diameter 
have been associated with hospital admissions 
and mortality due to cardiovascular causes 
in time series studies (Pope and Dockery 
2006). Mechanisms involving oxidative stress 
and inflammation have been proposed to 
explain these associations (Mills et al. 2007) 
(Figure 1). In addition, a growing toxicol­
ogy literature suggests that ultrafine particles 
(UFP), < 0.1 µm in diameter, may have 
greater potential to induce oxidative stress and 
inflammation than larger particles that domi­
nate PM2.5 and PM10 mass (Ntziachristos 
et al. 2007). This is likely because compared 
with larger particles, UFP have a higher air­
way deposition efficiency, magnitudes higher 
particle number (PN) concentration and sur­
face area, and higher concentrations of organic 
components shown to induce oxidative stress 
responses (Li et al. 2003). The ability of UFP 
to translocate systemically from pulmonary 
sites makes them particularly relevant to the 
cardiovascular effects of inhaled PM (Elder 
and Oberdörster 2006).
We aimed to improve the characterization 
of PM exposure in order to yield clues to poten­
tially important pollutant sources and causal 
component mixtures not otherwise evident 
with ambient PM2.5 and PM10 mass, which are 
regulated by the U.S. Environmental Protection 
Agency (Delfino et al. 2005) (Figure 1). For 
example, traffic (a common exposure source of 
redox active PM) increases spatial variability of 
UFP (Sioutas et al. 2005). Regional ambient 
data are thus likely to misrepresent personal 
exposure. In addition, ambient PM is made up 
of primary combustion aerosols, photochemi­
cally produced secondary organic aerosols, and 
mechanically generated crustal material. These 
particle types have different spatial and tempo­
ral variability. The organic component mix and 
size distribution differs as well between these 
two classes of particulate organic matter, with 
primary aerosols being more common in UFP 
and secondary aerosols more common in the 
accumulation mode (∼ 0.1–2.5 µm). 
To address these questions, we conducted 
a panel study with repeated measurements of 
biomarkers and exposures in 60 elderly indi­
viduals with a history of coronary artery disease 
(CAD), a population potentially susceptible 
to adverse effects of air pollution (von Klot 
et al. 2005). We investigated the relationship 
of intensive measurements of outdoor home 
air pollutants to changes in circulating bio­
markers of inflammation, platelet activation, 
and antioxidant capacity (Figure 1). These bio­
markers may be risk factors for cardiovascular 
diseases (Espinola­Klein et al. 2007; Pai et al. 
2004). We investigated the relative strength 
of biomarker associations between various PM 
size fractions. We also investigated differences 
in associations between exposure markers of 
traffic­related primary PM compared with sec­
ondary PM. Results presented here add a sec­
ond year of data from 31 subjects to data used 
in a previous analysis of 29 subjects (Delfino 
et al. 2008).
materials and methods
Population. We recruited subjects from four 
large retirement communities in the Los 
Angeles (LA), California, air basin. Three were 
in the San Gabriel Valley, closer to downtown 
LA and thus closer to traffic sources, and one 
was further inland in Riverside, California. 
Eligibility criteria included a confirmed CAD 
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Ba c k g r o u n d: Mechanisms involving oxidative stress and inflammation have been proposed 
to explain associations of ambient air pollution with cardiovascular morbidity and mortality. 
Experimental evidence suggests that organic components and ultrafine particles (UFP) are important. 
Me t h o d s : We conducted a panel study of 60 elderly subjects with coronary artery disease living 
in retirement communities within the Los Angeles, California, air basin. Weekly biomarkers of 
inflammation included plasma interleukin-6, tumor necrosis factor-α soluble receptor II (sTNF-
RII), soluble platelet selectin (sP-selectin), and C-reactive protein (CRP). Biomarkers of erythro-
cyte antioxidant activity included glutathione peroxidase-1 and superoxide dismutase. Exposures 
included outdoor home daily particle mass [particulate matter < 0.25, 0.25–2.5, and 2.5–10 µm 
in aero  dynamic diameter (PM0.25, PM0.25–2.5, PM2.5–10)], and hourly elemental and black carbon 
(EC–BC), estimated primary and secondary organic carbon (OCpri, SOC), particle number (PN), 
carbon monoxide (CO), and nitrogen oxides–nitrogen dioxide (NOx–NO2). We analyzed the rela-
tion of biomarkers to exposures with mixed effects models adjusted for potential confounders. 
re s u l t s: Primary combustion markers (EC–BC, OCpri, CO, NOx–NO2), but not SOC, were 
positively associated with inflammatory biomarkers and inversely associated with erythrocyte anti-
oxidant enzymes (n = 578). PN and PM0.25 were more strongly associated with biomarkers than 
PM0.25–2.5. Associations for all exposures were stronger during cooler periods when only OCpri, PN, 
and NOx were higher. We found weaker associations with statin (sTNF-RII, CRP) and clopidogrel 
use (sP-selectin). 
co n c l u s i o n s: Traffic-related air pollutants are associated with increased systemic inflammation, 
increased platelet activation, and decreased erythrocyte antioxidant enzyme activity, which may be 
partly behind air pollutant–related increases in systemic inflammation. Differences in association by 
particle size, OC fraction, and seasonal period suggest components carried by UFP are important.
key w o r d s : cytokines, enzymes, epidemiology, longitudinal data analysis, oxidative stress. Environ 
Health Perspect 117:1232–1238 (2009).  doi:10.1289/ehp.0800194 available via http://dx.doi.org/ 
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history, ≥ 65 years of age, nonsmoker, and 
unexposed to environmental tobacco smoke. 
We clinically evaluated 105 potentially eligible 
subjects on site. Twenty­one subjects were not 
eligible, and 20 dropped out or had too few 
blood draws (< 5 of 12 weeks), leaving 64 sub­
jects. Four subjects had insufficient biomarker 
data, mostly because of exclusions for frequent 
infections, leaving 60 subjects ≥ 71 years of 
age with 5–12 weekly blood draws (n = 578) 
(Table 1). The study protocol was approved by 
the Institutional Review Board of the University 
of California, Irvine, and we obtained informed 
written consent from subjects.
Two communities were studied in 
2005–2006 (29 subjects) and two communi­
ties were studied in 2006–2007 (31 subjects). 
We studied subjects in two periods to enhance 
known contrasts across the LA basin in particle 
composition and size distribution by season 
(Sioutas et al. 2005). In each community, we 
collected 6 weeks of data during a period of 
higher temperature (July−mid­October), and 
thus higher photochemical activity and mixing 
depths, and 6 weeks of data during a cooler 
period (mid­October−February), with more 
frequent periods of air stagnation and lower 
mixing heights (when traffic­related primary 
air pollutants increase at ground level). Over 
a 7­month period, each subject was followed 
weekly in these two 6­week blocks with blood 
draws for circulating biomarkers of inflamma­
tion and antioxidant activity. Subjects com­
pleted daily diaries reporting medication use. 
Biomarkers. Venous peripheral blood sam­
ples were drawn at the same time of day and 
day of week (Friday afternoons) and rapidly 
separated within 30 min into erythrocytes and 
plasma and frozen at our on­site mobile field 
laboratory. For the current analysis, we focused 
on biomarkers that were most informative in the 
previous analysis of first­year data (Delfino et al. 
2008). Plasma samples stored at –80°C were 
thawed and assayed using 96­well immuno  assay 
kits for the proinflammatory cytokines inter­
leukin­6 (IL­6) and tumor necrosis factor­α 
(TNF­α) (Quantikine HS, R&D Systems, 
Minneapolis, MN), soluble TNF­α receptor II 
(sTNF­RII) (Quantikine, R&D Systems), the 
acute­phase protein C­reactive protein (CRP) 
(Zymutest, Hyphen BioMed, Neuville­sur­
Oise, France), and a marker of platelet activa­
tion, soluble platelet selectin (sP­selectin) (Jurk 
and Kehrel 2005). Frozen­thawed erythrocyte 
lysates were assayed spectrophotometrically for 
activities of two antioxidant enzymes, gluta­
thione peroxidase­1 (GPx­1) and copper–zinc 
superoxide dismutase (Cu,Zn­SOD) (Cayman 
Chemical, Ann Arbor, MI), normalized to units 
per gram of hemoglobin (U/g Hb).
Exposure assessment. Measurement 
methods are more thoroughly described in 
the Supplemental Material (doi:10.1289/
ehp.0800194.S1). Hourly outdoor home air 
pollutants were measured over 9 days before 
each blood draw as described elsewhere (Arhami 
et al. 2006; Polidori et al. 2007). These meas­
urements included pollutant gases [carbon 
monoxide, nitrogen oxides–nitrogen dioxide 
(NOx–NO2), ozone], total PN (condensa­
tion particle counter model 3785; TSI Inc, 
Shoreview, MN), PM2.5 organic carbon (OC) 
and elemental carbon (EC) (OC_EC analyzer 
model 3F; Sunset Laboratory Inc., Tigard, OR), 
and black carbon (BC) (aethalometer; Magee 
Scientific, Berkeley, CA). We also measured 
size­fractionated PM mass with the Sioutas per­
sonal cascade impactor sampler (SKC, Inc., 
Eighty Four, PA) over 24­hr periods from 
mid­afternoon to mid­afternoon for 5 days 
before each blood draw (unlike hourly pollut­
ants meas  ured 9 days before). This included 
particles 0–0.25 µm in diameter (PM0.25), 
accumulation­mode particles 0.25–2.5 µm in 
diameter (PM0.25–2.5), and coarse mode par­
ticles 2.5–10 µm in diameter (PM2.5–10). We 
refer to PM0.25 as “quasi­ultrafine” because the 
upper size cutpoint for the ultrafine mode has 
varied from 0.1 to 0.2 µm, depending on loca­
tions and seasons. UFP are traditionally defined 
as those originating mostly from fresh emis­
sion sources and accounting for > 90% of the 
number­based particle concentrations (Sioutas 
et al. 2005). A major fraction of accumulation­
mode PM originates from the ultrafine mode. 
Figure 1. Pathways from PM exposure to measured changes in systemic biomarkers and to hypothesized 
adverse cardiovascular health effects. The different source characteristics and particle-size fractions we 
measured represent different types and concentrations of redox active components, including organic 
chemicals (we measured OC), that may lead to the production of reactive oxygen species in various cells 
of the lungs, blood, and vascular tissues. This will induce oxidative stress and then antioxidant responses 
from enzymes involved in oxidant defense, either by interacting with a relatively fixed pool of erythrocyte 
enzymes (we measured GPx-1 and Cu,Zn-SOD) or through induction of genes coding these enzymes in 
nucleated cells. Proinflammatory effects (we measured IL-6, TNF-α, sTNF-RII, and CRP) then occur at 
higher levels of exposure-induced oxidative stress when antioxidant defenses are overwhelmed (Li et al. 
2003). This is expected to lead to upregulation of adhesion molecules on vascular endothelium, circulating 
leukocytes, and platelets (we measured sP-selectin). Induction of endothelial dysfunction, inflammation, 
and thrombosis by these mechanisms would increase the risk of acute adverse cardiovascular outcomes. 
Repeated acute insults such as these likely contribute to atherogenesis. 
Characterized short-term PM exposure
Redox active PM components
Oxidative stress
Systemic inﬂammation
(IL-6, TNF-α, sTNF-RII, and CRP)
Platelet activation
(sP-selectin)
Potential cardiovascular clinical outcomes
Acute:    cardiovascular stress (    blood pressure, heart rate, and myocardial contractility)
Chronic:  Progression of atherosclerotic lesions
Cardiac ischemia Arrhythmias and cardiac arrest
Systemic antioxidant defense
(erythrocyte GPx-1 and Cu, Zn-SOD)
Source origin:
outdoor/indoor
Source composition:
OCpri/SOC
Size fraction:
PM0.25, PM0.25–2.5, PM2.5–10
Table 1. Characteristics of subjects (n = 60).
Characteristic Value
Age (years) 84.1 ± 5.60
Body mass index (kg/m2)  26.8 ± 3.87
Sex 
  Male 34 (56.7)
  Female 26 (43.3)
Cardiovascular history
  Confirmation of CADa
  Myocardial infarction 27 (45.0)
  Coronary artery bypass graft  
    or angioplasty
20 (33.3)
  Positive angiogram or stress test 10 (16.7)
  Clinical diagnosisb 3 (5.0)
  Current angina pectoris 18 (30.0)
  Congestive heart failure 13 (21.7)
  Hypertension 42 (70.0)
  Hypercholesterolemia (by history) 43 (71.7)
Medications
  ACE inhibitors and angiotensin II  
  receptor antagonists
24 (40.0)
  HMG-CoA reductase inhibitors (statins) 31 (51.7)
  Clopidogrel bisulfate (Plavix)c 21 (35.0)
Values are mean ± SD or no. (%).
aEach category is hierarchical and excludes being in the 
above diagnostic category. bIncludes subjects with angi-
nal symptoms relived with nitrates plus echocardiogram 
and ECG evidence of past infarct. cEight were also taking 
coumadin.Delfino et al.
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This is unlike coarse particles and fine particles 
(PM2.5, or accumulation plus ultrafine), which 
are naturally divided by a cutpoint of 2.5 µm 
and have clearly different origins. 
We estimated outdoor secondary OC 
(SOC) and primary OC (OCpri) from 
total OC as detailed in our recent publica­
tion (Polidori et al. 2007) and summarized 
in the Supplemental Material (doi:10.1289/
ehp.0800194.S1). OCpri is representative of 
particles emitted directly from combustion 
sources (mostly fossil fuels in the LA basin), 
whereas SOC represents semivolatile and low­
volatile products of photochemical reactions 
involving reactive organic gases from anthro­
pogenic and biogenic sources. The study aver­
age outdoor SOC accounted for 34% and 
44% of total OC in the cooler and warmer 
phases, respectively.
Analysis. We used linear mixed­effects mod­
els to analyze relationships of biomarkers to air 
pollutant exposures (Verbeke and Molenberghs 
2001). Because within­individual repeated 
measures of outcomes are correlated, random 
effects were estimated at the subject level, nested 
within phase and community. The covariance 
structure observed from empiric variograms was 
representative of an autoregressive­1 correlation, 
and models were fit as such. 
Using mean centered exposures, we 
adjusted for between­subject group and 
between­phase exposure effects. Thus, the 
interpretation of reported estimates is at 
the subject level [see Supplemental Material 
(doi:10.1289/ehp.0800194.S1)]. 
To assess more acute versus cumulative 
exposure–response relationships, we evaluated 
last 24­hr averages of air pollutants (1 day) as 
well as cumulative exposures up to 9 days (or 
5 days for particle mass) before the blood draw. 
We chose a set of averaging times that skipped 
over averages by 1 day to simplify the presenta­
tion while still presenting a view of associa­
tions across the span of averaging times (1­day, 
3­day, 5­day, 7­day, and 9­day averages). 
We decided a priori to exclude person­
weeks with acute infectious illnesses, given 
their known impact on measured biomarkers. 
We controlled for temperature at the same 
averaging time as the air pollutant. 
We hypothesized a priori that medication 
variables known to influence inflammation 
and oxidative stress would act as effect modifi­
ers. This included 3­hydroxy­3­methylglutaryl 
coenzyme A (HMG CoA) reductase inhibi­
tors (statins), and angiotensin­converting 
enzyme (ACE) inhibitors or angiotensin II 
receptor blockers (ARB). We also tested effect 
modification of sP­selectin associations by 
clopidogrel, a platelet aggregation inhibitor. 
We tested differences in association by 
seasonal phase of study to gain clues regard­
ing underlying differences in potentially 
important air pollutant components. In 
addition, given the known differences in air 
pollution in the San Gabriel Valley (three 
communities) compared with Riverside (one 
community), we tested differences in associa­
tion between these regions. We planned these 
analyses in advance by designing the study to 
follow subjects during two seasonal phases 
and in different regions, known factors lead­
ing to differences in pollutant components 
and particle size distribution. All interactions 
(medications, phase, and group) were tested 
in product term models and all stratified 
results come from these models including 
all data. 
Associations were more strongly posi­
tive in the San Gabriel Valley (44 subjects) 
than in Riverside (16 subjects) for sTNF­RII 
and sP­selectin [see Supplemental Material 
(doi:10.1289/ehp.0800194.S1)]. To sim­
plify model presentation, we show results for 
sTNF­RII and sP­selectin for subjects in the 
three San Gabriel Valley communities.
We examined residual diagnostics to 
investigate deviations from standard linear 
mixed­model assumptions (functional form 
of independent variables and covariance 
assumptions) and the presence of influential 
observations. Four influential high outliers 
for IL­6 > 10 pg/mL were reset to 10 pg/mL, 
and one extreme influential outlier for sP­
selectin (221 ng/mL) was removed to obtain 
more representative estimates of association. 
Residuals for both CRP and TNF­α exhibited 
a highly skewed distribution, primarily due to 
a cluster of subjects in the upper quartile of 
biomarker concentrations, and 2–3 high out­
liers > 3 SD above the mean. Outliers were 
reset to the next highest values, and secondary 
subgroup analyses were conducted among 
subjects in the upper quartile of mean CRP 
versus the lower three quartiles. Although this 
analysis was clearly data driven, similar sub­
group analyses have been previously reported 
(Dubowsky et al. 2006; Rückerl et al. 2006). 
Table 2. Biomarker concentrations (578 measurements).
Biomarkera  Mean ± SD  Median (min/max)
IL-6 (pg/mL)  2.42 ± 1.85  1.92 (0.25/10.0)
TNF-α (pg/mL)b  1.92 ± 1.64  1.41 (0.5/14.3)
sTNF-RII (pg/mL)  3,610 ± 1,489  3,235 (657/11,584)
sP-selectin (ng/mL)  45.0 ± 16.6  42.5 (6.0/119.9)
CRP (ng/mL)c  2,434 ± 3,181  1,403 (250/26,799)
Cu,Zn-SOD (U/g Hb)  4,459 ±1,688  4,288 (669/13,138)
GPx-1 (U/g Hb)  19.2 ± 7.6  17.8 (5.5/50.7)
Abbreviations: max, maximum; min, minimum.
aExcludes observations for weeks when there was a reported infection. bValues of TNF-α < 0.5 could not be quantified 
and were set to 0.5. cValues of CRP < 250 could not be quantified and were set to 250. 
Table 3. Descriptive statistics of outdoor air pollutant measurements.
  Phase 1  Phase 2     
Exposure (24-hr average)  No. (missing)  Mean ± SD  IQR  Min/max  No. (missing)  Mean ± SD  IQR  Min/max  IQR overalla
Outdoor hourly PM        
  EC (µg/m3)  161 (19)  1.45 ± 0.52  0.706  0.53/3.01  139 (34)  1.55 ± 0.71  1.08  0.24/3.94  0.87
  OC (µg/m3)  164 (16)  7.90 ± 4.65  4.43  2.32/27.26  141 (32)  9.25 ± 4.33  7.62  2.51/17.72  7.59
  BC (µg/m3)  180 (0)  1.59 ± 0.63  0.86  0.38/3.37  172 (1)  1.76 ± 0.91  1.24  0.30/5.11  1.03
  OCpri (µg/m3)  161 (19)  4.36 ± 2.14  2.91  1.28/10.04  139 (34)  6.03 ± 3.53  6.25  0.99/13.64  4.04
  SOC (µg/m3)  161 (19)  3.48 ± 3.40  2.03  0.28/18.74  139 (34)  3.12 ± 1.62  2.50  0.00/6.91  2.42
  PN/cm3  133 (47)  10,243 ± 4,438  6,526  1,441/24,302  152 (21)  14,851 ± 6,490  8,631  3,297/31,264  7,354
Outdoor PM mass       
  PM0.25 (µg/m3)  111 (9)  10.27 ± 3.69  4.79  3.16/22.82  106 (7)   9.25 ± 4.48  5.60  2.46/30.05  7.00
  PM0.25–2.5 (µg/m3)  115 (5)  12.23 ± 6.39  9.54  1.64/27.78  111 (2)   10.47 ± 11.70  9.95  0.98/66.77  10.58
  PM2.5–10 (µg/m3)  110 (10)  11.45 ± 4.65  5.32  1.15/23.41  107 (6)   7.25 ± 4.39  5.22  0.30/24.63  5.46
Outdoor hourly gases        
  NO2 (ppb)  179 (1)  26.41 ± 11.97  19.17  4.52/59.83  172 (1)  28.34 ± 11.80  17.57  3.78/55.74  14.30
  NOx (ppb)  179 (1)  37.17 ± 22.44  28.13  3.70/112.43  172 (1)  53.86 ± 36.14  50.9  4.26/188.0  41.60
  CO (ppm)  173 (7)  0.50 ± 0.25  0.36  0.11/1.30  162 (11)  0.58 ± 0.35  0.52  0.01/1.68  0.51
 O 3 (ppb)  179 (1)  33.30 ± 11.40  15.52  8.04/76.35  170 (3)  20.62 ± 8.04  10.8  6.17/44.90  16.09
Abbreviations: IQR, interquartile range; max, maximum; min, minimum. 
aThis overall IQR was used to estimate the expected change in the biomarker (coefficient and 95% CI) from exposure to the air pollutant.Circulating biomarkers and air pollution
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Mixed­models analyses for both CRP and 
TNF­α were stratified as such to show dif­
ferential risk by chronic inflammation and 
to express results for both variables in their 
measured units.
To identify influential subject clusters, 
we tested random slopes models as well as 
individual autoregressive models. Through 
this exploratory data analysis, we found that 
five subjects in erythrocyte Cu,Zn­SOD 
models and three subjects in erythrocyte 
GPx­1 models formed highly influential 
clusters with positive associations between 
air pollutants and biomarkers. One subject 
was a positive responder for both biomarkers 
[see Supplemental Material (doi:10.1289/
ehp.0800194.S1)]. Below, we present results 
for secondary analyses excluding these influ­
ential subjects. Because these results stem 
from a sensitivity analysis, the reported results 
should be interpreted conservatively.
Results
Descriptive statistics. Descriptive data for bio­
marker measurements are shown in Table 2. 
Table 3 gives descriptive statistics for exposures 
by phase of study. Exposures were generally 
similar across the two phases, except for nota­
bly higher concentrations of OCpri, PN, and 
NOx in phase 2 (colder phase), and higher 
concentrations of SOC and O3 in phase 1 
(warmer phase). High outdoor PM0.25 relative 
to PM2.5 are likely attributable to large impacts 
of local traffic in the LA basin compared with 
the eastern half of the nation with much larger 
contributions to PM2.5 from accumulation­
mode sulfate aerosols. Table 4 shows expo­
sure correlations for combined phases. EC, 
BC, OCpri, NOx, and CO were strongly cor­
related with each other, likely because they 
are products of fossil fuel combustion. These 
correlations were stronger in phase 2 than in 
phase 1 (data not shown). PN and PM0.25 
concentrations were moderately correlated 
with these combustion­related pollutants, and 
these correlations were stronger in the three 
San Gabriel Valley communities closer to traf­
fic sources than in Riverside (data not shown). 
There is a stronger correlation between PM0.25 
and PM2.5–10 (coarse particles) than between 
PM0.25 and PM0.25–2.5 because PM0.25 and 
coarse particles come from primary traffic 
sources in our study region. Whereas PM0.25 
is primarily a product of fresh emissions, 
PM0.25–2.5 is a product of aging and photo­
chemical reactions. 
Regression analysis. Many positive asso­
ciations were found for IL­6, sP­selectin, 
sTNF­RII, TNF­α, and CRP with markers 
of traffic­related air pollution (EC, OCpri, BC, 
NOx, and CO). We also found inverse asso­
ciations of Cu,Zn­SOD and GPx­1 with the 
same pollutants. However, this was found only 
in the restricted subset of 55 (Cu,Zn­SOD) 
and 57 subjects (GPx­1) as presented below, 
whereas models including all 60 subjects 
were mostly nonsignificant [see Supplemental 
Material (doi:10.1289/ehp.0800194.S1)]. To 
simplify the presentation, we focus here on 
two biomarkers of inflammation (IL­6 and 
sTNF­RII) and present results for TNF­α 
and CRP online [see Supplemental Material 
(doi:10.1289/ehp.0800194.S1)]. We also 
present results for two key markers of primary 
combustion (EC and OCpri) that were strongly 
correlated with the other markers not shown 
(BC, NOx, and CO). We present pollutant 
averaging times here that best represent asso­
ciations across the span of time rather than the 
full set of selected averaging times. In many 
but not all cases, associations were strongest 
for longer­term averages out to the last 5 days 
and, in some cases, 9 days. Regression results 
for all pollutants and all selected lag averages 
are shown online [see Supplemental Material 
(doi:10.1289/ehp.0800194.S1)].
Biomarkers of systemic inflammation 
(IL­6 and sTNF­RII), but not sP­selectin, 
were more strongly and significantly associated 
with quasi­ultrafine PM0.25 than larger­size 
fractions (Figure 2). We also found inverse 
associations of Cu,Zn­SOD and GPx­1 with 
PM0.25 that were somewhat stronger than 
larger­size fractions. 
Across all biomarkers, we also found con­
sistently stronger associations for OCpri than 
for SOC, and this was generally reflected by 
Table 4. Outdoor exposure correlation matrix.a
  OC  BC  OCpri  SOC  PN  PM0.25  PM0.25–2.5  PM2.5–10  NO2  NOx  CO  O3
EC  0.61  0.89  0.97  –0.03  0.50  0.54  0.31  0.36  0.80  0.82  0.78  –0.39
OC  1.00  0.63  0.65  0.72  0.27  0.41  0.33  0.33  0.55  0.46  0.59  –0.05
BC    1.00  0.88  0.07  0.40  0.52  0.43  0.44  0.88  0.83  0.79  –0.38
OCpri      1.00  0.01  0.47  0.55  0.33  0.36  0.78  0.79  0.75  –0.36
SOC        1.00  –0.08  0.09  0.16  0.15  0.07  –0.09  0.11  0.26
PN          1.00  0.36  –0.12  0.06  0.48  0.63  0.45  –0.38
PM0.25             1.00  0.17  0.35  0.56  0.51  0.54  0.01
PM0.25–2.5               1.00  0.60  0.19  0.01  0.13  0.08
PM2.5–10                1.00  0.32  0.18  0.26  0.06
NO2                  1.00  0.88  0.79  –0.42
NOx                    1.00  0.82  –0.53
CO                      1.00  –0.29
aAll exposures are mean-centered by group and phase [see Supplemental Material (doi:10.1289/ehp.0800194.S1)]. 
Figure 2. Associations of biomarkers with outdoor size-fractionated particle mass on days 1, 3, and 5. Expected change in the biomarker (adjusted coefficient 
and 95% confidence interval) corresponds to an interquartile range change in the air pollutant (Table 3). Models for sTNF-RII and sP-selectin are restricted to 
44 subjects living in the San Gabriel Valley. 
1.2
1.0
0.8
0.6
0.4
0.2
0.0
–0.2
–0.4
–0.6
400
350
300
250
200
150
100
50
0
–50
–100
–150
10
9
8
7
6
5
4
3
2
1
0
–1
–2
–3
–4
200
100
0
–100
–200
–300
–400
–500
1.0
0.5
0.0
–0.5
–1.0
–1.5
–2.0
–2.5
I
L
-
6
 
(
p
g
/
m
L
)
s
T
N
F
-
R
I
I
 
(
p
g
/
m
L
)
s
P
-
s
e
l
e
c
t
i
n
 
(
n
g
/
m
L
)
C
u
,
 
Z
n
-
S
O
D
 
(
U
/
g
 
H
b
)
G
P
x
-
1
 
(
U
/
g
 
H
b
)
1351 35 1
PM0.25 PM2.5–10 PM0.25–2.5
35 1351 35 1
PM0.25 PM2.5–10 PM0.25–2.5
35 1351 35 1
PM0.25 PM2.5–10 PM0.25–2.5
35 1351 35 1
PM0.25 PM2.5–10 PM0.25–2.5
35 1351 35 1
PM0.25 PM2.5–10 PM0.25–2.5
35
Moving averages of air pollutants over the previous 5 days Delfino et al.
1236  v o l u m e  117 | n u m b e r 8 | August 2009  •  Environmental Health Perspectives
confidence intervals (CIs) for total OC that 
usually crossed zero (Figure 3). 
Associations were generally stron­
ger in phase 2 than in phase 1 for IL­6, 
Cu,Zn­SOD, and sP­selectin (Figure 4). The 
panels were marginally different across phases, 
because subjects were followed in two phases 
with few exceptions (5 of 60 subjects). In 
models restricted to 55 subjects with data in 
both phases, phase differences were nearly 
unchanged (data not shown). 
Furthermore, associations were stron­
ger among subjects not taking statins for 
sTNF­RII and stronger among subjects not 
taking clopidogrel for sP­selectin (Figure 5). 
There were few consistent pollutant inter­
actions with ACE/ARB.
As previously reported and discussed 
for year 1 data (Delfino et al. 2008) but not 
presented here, regression coefficients for 
ozone had opposite signs compared with 
other pollutants [see Supplemental Material 
(doi:10.1289/ehp.0800194.S1)] and were 
completely confounded by markers of primary 
combustion (EC, BC, OCpri, CO, NOx) with 
which O3 was inversely correlated (Table 4). 
Discussion
Our results are largely consistent with recent 
repeated­measures studies showing associa­
tions between ambient air pollution and bio­
markers of systemic inflammation in healthy 
young adults (Chuang et al. 2007) and sus­
ceptible subjects with CAD (Dubowsky et al. 
2006; Rückerl et al. 2006, 2007a; 2007b; Yue 
et al. 2007). We extended these previous find­
ings with data from intensive home exposure 
assessments and modeling that provided clues 
to potentially causal pollutant components. 
This is also the first study to show adverse 
effects of air pollutants on erythrocyte anti­
oxidant enzymes. 
We focused on elucidating the role of pol­
lutants closely associated with traffic, including 
EC and PM0.25. This was accomplished with 
extensive measurements of exposures in the 
immediate outdoor community microenviron­
ments of subjects, including size­fractionated 
PM, OC fractions, and measurements across 
seasons that helped us characterize differences 
in response potentially due to particle size 
distribution and chemical composition. The 
approach likely enabled us to detect stronger 
associations with PM0.25 than PM0.25–2.5 
(Figure 2). Such differences in these two parti­
cle­size fractions of regulated fine PM (PM2.5) 
have not been as clearly demonstrated in pre­
vious panel studies that have relied on central 
site data. This finding may be attributable to 
the higher deposition fraction of the unmeas­
ured UFP fraction (PM0.1) of PM0.25 than 
accumulation­mode particles and the ability 
of UFP to translocate systemically to poten­
tially induce oxidative stress and inflammation 
(Elder and Oberdörster 2006; Li et al. 2003). 
The approach also enabled us to demon­
strate for the first time that associations of 
IL­6, sP­selectin, and SOD with PM mark­
ers of primary combustion (EC, OCpri), PN, 
and PM0.25 were stronger in a cooler 6­week 
period (phase 2) than a warmer 6­week period 
(phase 1) (Figure 4). We did not find any 
positive associations with SOC (Figure 3), 
with most regression coefficients being nega­
tive and nonsignificant at p < 0.05. OCpri 
and PN concentrations were higher in cooler 
months (typically characterized by air stag­
nation and lower secondary particle forma­
tion). Interestingly, concentrations of other 
Figure 3. Associations of biomarkers with indoor and outdoor OC on days 1, 3, and 5: differences by OCpri and SOC fractions. Expected change in the biomarker 
(adjusted coefficient and 95% CI) corresponds to an interquartile range change in the air pollutant (Table 3). Models for sTNF-RII and sP-selectin are restricted to 
44 subjects living in the San Gabriel Valley. 
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pollutants also more strongly associated with 
biomarkers in the cooler phase (EC, BC, and 
PM0.25) were not higher, suggesting that dif­
ferences in particle composition or size dis­
tribution were important, perhaps as better 
reflected by OCpri and PN, respectively. This 
is an important finding because particle mass 
alone does not provide sufficient information 
about composition or sources. It is conceiv­
able, for example, that our findings for PM0.25 
and PN are attributable partly to nanoparti­
cles. It has been shown that particles 6–12 nm 
were much higher in the winter than in the 
summer near a Los Angeles freeway, but larger 
particles 50–100 nm showed the opposite 
trend (Zhu et al. 2004). The potential impor­
tance of traffic­related particles is supported 
by stronger positive associations for sTNF­
RII and sP­selectin in the San Gabriel Valley 
communities closer to traffic sources than in 
the Riverside community. Associations were 
also generally stronger for OCpri (Figure 3) 
than for PM0.25 (Figure 2). OCpri and related 
EC are mostly associated with UFP (Li et al. 
2003). Because PM0.25 includes some accu­
mulation­mode particles, it likely represents 
both fresh and aged traffic­related particles. 
Based on these results, both primary organic 
components and quasi­ultrafine or smaller­
size fractions appear to be important.
Semivolatile organic components associated 
with particles may also have been important, 
given that biomarker associations were similarly 
robust for the correlated gases CO and NOx 
[see Supplemental Material (doi:10.1289/
ehp.0800194.S1)]. This included generally 
stronger associations with gases in phase 2 than 
in phase 1 when NOx concentrations were 
lower. These gases were unlikely causal at the 
observed low concentrations (Devlin et al. 
1999; Thom et al. 2006) but instead served as 
markers for other traffic emission components. 
Other findings support the hypothesis that 
effects of air pollution on cardiovascular health 
are secondary to proinflammatory properties 
of redox active and other pollutant compo­
nents (Delfino et al. 2005). Associations for 
sTNF­RII were stronger in subjects not taking 
statins, which have anti­inflammatory proper­
ties. These findings are consistent with reports 
of weaker associations between air pollutants 
and CRP among statin users in two other 
panel studies of susceptible elderly subjects 
(Dubowsky et al. 2006; Rückerl et al. 2006). 
Our new finding for sP­selectin is con­
sistent with a panel study showing an asso­
ciation of ambient UFP with another platelet 
activation marker (soluble CD40 ligand) in 
people with CAD (Rückerl et al. 2007b). Our 
study is the first to show a protective effect of 
clopidogrel. This finding supports the plausi­
bility of a pollutant effect on platelet activa­
tion, because this medication blocks platelet 
aggregation and is associated with decreased 
sP­selectin (Xiao and Théroux 2004). Our 
findings are relevant to the potential for air 
pollution to affect CAD, because sP­selectin 
activates both leukocytes and endothelial cells 
and induces adhesion of leukocytes to plate­
lets and to endothelial cells (Jurk and Kehrel 
2005). Therefore, if air pollutants acutely 
activate platelets as suggested by our finding, 
this could increase the risk of a potentially 
fatal thrombotic event in the coronary arteries 
(Figure 1). Platelet selectin is also critical to 
the development of neointimal formation after 
arterial injury (Wang et al. 2005). Potentially 
relevant findings by two epidemiologic studies 
are evidence of increased risks of athero  sclerosis 
development with exposure to traffic­related 
air pollution near the home (Hoffmann et al. 
2007; Künzli et al. 2005).
Other novel findings are the inverse asso­
ciations between air pollutants and two anti­
oxidant enzymes (GPx­1 and Cu,Zn­SOD). 
Experimental results show that urban UFP 
can induce a positive antioxidant response 
represented by hemoxygenase­1 in epithelial 
and macrophage cell cultures (Li et al. 2003). 
However, erythrocytes do not have nuclei 
and thus have a relatively fixed amount of 
antioxidant enzymes after maturation from 
reticulocytes. The findings for GPx­1 and 
Cu,Zn­SOD in most of the elderly subjects 
studied suggest enzyme inactivation within 
erythrocytes by pollutant components or 
PM0.25. There is experimental evidence to 
support this hypothesis (Hatzis et al. 2006; 
Pigeolet et al. 1990; Shinyashiki et al. 2008) 
as well as evidence showing that quasi­UFP 
≤ 0.2 µm in diameter and nanoparticles, but 
not larger particles, freely enter the erythrocyte 
(Rothen­Rutishauser et al. 2006). This may 
be a clue to an important pathway involving 
primarily UFP (Elder and Oberdörster 2006) 
and related organic and inorganic compo­
nents that may enter the circulation to then 
target erythrocytes as well as other cells. 
Erythrocytes are critical in protecting 
the body against oxidative stress (Tsantes 
et al. 2006). Therefore, it is conceivable that 
erythrocyte antioxidant enzyme inactivation 
is partly responsible for pollutant­related 
increase in biomarkers of inflammation and 
thrombosis. This is supported by our finding 
of within­subject inverse associations of IL­6 
with GPx­1, and sP­selectin with Cu,Zn­SOD 
in mixed models. For an interquartile range 
decrease in GPx­1 of 10.4 U/g hemoglobin, 
IL­6 increased 0.25 pg/mL (95% CI, −0.03 
to 0.53) or 10% of mean IL­6. Similarly, for 
an interquartile range decrease in SOD of 
2,026 U/g hemoglobin, sP­selectin increased 
5.8 ng/mL (95% CI, 3.3 to 8.3), or 13% of 
mean sP­selectin. Biomarkers of inflamma­
tion were generally positively associated with 
each other, and GPx­1 was positively asso­
ciated with Cu,Zn­SOD (data not shown). 
Furthermore, erythrocyte antioxidant enzyme 
inactivation may modulate the putative effects 
of air pollutants on endothelial dysfunc­
tion. Erythrocytes have been shown to pro­
tect cultured endothelial cells against oxidant 
damage. Inhibitors of either the erythrocyte 
glutathione system or membrane transport 
of superoxide into erythrocytes significantly 
reduced this protection (Richards et al. 1998).
A small subset of subjects showed positive 
GPx­1 and Cu,Zn­SOD associations with 
air pollutants. Compared with the 53 nega­
tive responders, these seven subjects showed 
no notable differences in the distributions of 
characteristics listed in Table 1 except that 
none took clopidogrel and only one had a 
history of myocardial infarction. We spec­
ulate that these might be healthier subjects 
because of their ability to increase antioxi­
dant enzyme activity, perhaps by mounting a 
rapid bone marrow response to PM exposure, 
as suggested in several experimental stud­
ies (Goto et al. 2004; Mukae et al. 2001), 
including increased reticulocytes (Rivero et al. 
2005). In mature erythrocytes, activities of 
Cu,Zn­SOD and GPx­1 are steadily eroded 
Figure 5. Associations of biomarkers with outdoor air pollutants on days 1, 3, 5, and 9: differences by medi-
cation use among 44 subjects living in the San Gabriel Valley. (A) sTNF-RII (pg/mL). (B) sP-selectin (ng/mL). 
Expected change in the biomarker (adjusted coefficient and 95% CI) corresponds to an interquartile range 
change in the air pollutant (Table 3).
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by oxidative and nitrosative stress as they age. 
Consequently individuals with robust erythro­
poietic activity and greater proportion of 
newly released erythrocytes would be expected 
to have higher erythrocyte Cu,Zn­SOD and 
GPx­1 activities than sicker individuals. 
Study limitations include the following: 
Despite the biological plausibility, effect mod­
ification by medication use could have been 
secondary to other unmeasured characteristics 
of subjects. The home exposure data may be 
subject to exposure error because of differ­
ences with personal exposure. However, sub­
jects stayed at home 88% of the time (from 
diary data). Although we believe that the 
present exposure data represent key sources 
and components, we cannot link exposure to 
specific sources, nor can we identify specific 
component classes such as polycyclic aromatic 
hydrocarbons as being responsible for asso­
ciations. Nevertheless, the major source of 
fossil fuel emissions in the LA basin is motor 
vehicle exhaust, and because EC, BC, OCpri, 
CO, and NOx are linked to these emissions, 
our data suggest that vehicular pollutants are 
behind the reported associations.
Conclusion
Our results suggest that pollutant compo­
nents linked to emission sources of primary 
PM2.5 OC, quasi­UFP (PM0.25), and PN con­
centrations are associated with increased sys­
temic inflammation, platelet activation, and 
decreased circulating erythrocyte antioxidant 
enzyme activity in elderly people with CAD. 
Inactivation of antioxidant enzymes may be one 
mechanism of air pollutant–related increases in 
systemic inflammation. These effects may be 
partly behind reported morbidity and mortality 
associations with ambient PM2.5 mass concen­
trations (Pope and Dockery 2006). Stronger 
associations during the cooler phase of study, 
despite similar PM0.25 mass concentrations 
in cooler and warmer phases, further support 
the view that the greatest impacts on systemic 
responses may be attributable to nanoparticles 
not adequately represented by the present par­
ticle mass measurements as well as to unmea­
sured toxic air pollutants that increase near 
ground level in the winter. Our related experi­
mental work using particles collected in the LA 
air basin at the Southern California Particle 
Center suggests that this might include redox 
active and electrophilic organic components of 
traffic exhaust particles in the ultrafine range 
(Araujo et al. 2008; Gong et al. 2007; Li et al. 
2003; Ntziachristos et al. 2007; Shinyashiki 
et al. 2008).
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